戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 after administration of hetastarch 35 mL/kg (hypervolemia).
2 belief that CHF is associated with long-term hypervolemia.
3 in 30% of KTRs, with 5% classified as severe hypervolemia.
4 is study were to establish the prevalence of hypervolemia among clinically stable KTRs, investigate t
5 scaling relation may indicate hypovolemia or hypervolemia and aid diagnosis.
6 and/or saline intake to prevent or attenuate hypervolemia and hypernatremia.
7 poxemia, hypercarbia, acidosis, hypothermia, hypervolemia, and increased intrathoracic pressure).
8 postural thoracic hypovolemia and splanchnic hypervolemia are associated with postural simple faint.
9 investigate the predictors of posttransplant hypervolemia, assess its impact on blood pressure, and d
10                                         With hypervolemia, cardiac output increased at low-level CPAP
11 xcessive thoracic hypovolemia and splanchnic hypervolemia during orthostasis compared with healthy su
12 perkalemia [>= 6 mmol/L], diuretic-resistant hypervolemia, high urea serum levels [>= 150 mg/dL], sev
13  use of DSR as a method to prevent and treat hypervolemia in heart failure is warranted.
14           The prevalence and consequences of hypervolemia in kidney transplant recipients (KTRs) have
15                            In the absence of hypervolemia, intravenous fluid delivery is frequently t
16 reased cardiac output with low-level CPAP in hypervolemia is associated with systemic vasodilation.
17   Close monitoring of fluid balance to avoid hypervolemia is essential.
18                                              Hypervolemia is unexpectedly common among clinically sta
19 vels were independently associated with both hypervolemia (P=0.01) and allograft dysfunction (P=0.03)
20                                              Hypervolemia was present in 30% of KTRs, with 5% classif
21                                              Hypervolemia was the only independent predictor of eleva
22                              Mild and severe hypervolemia were defined as percentage volume expansion
23 ts hospitalized for HF with > or =2 signs of hypervolemia were randomized to ultrafiltration or intra
24 entration in patients who have euvolemia and hypervolemia with hyponatremia in the short term (</=30